T-group (topology)
5069.1.1 Transmembrane di-heme cytochromes
Ligands and drugs
3,482
Member domains
561
with ligand contacts (≤ 4 Å)
16.1% of members
361
with DrugDomain annotations
10.4% of members
348
with a DrugBank compound
10.0% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 5069.1.1 belongs to X-group 5069 Transmembrane heme-binding four-helical bundle, which binds 7.6 ligand superclasses per 20 proteins, narrower than 50% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB18267 | HEM | Ferroheme | 291 |
| DB03429 | CDL | Tetrastearoyl cardiolipin | 126 |
| DB04327 | PEE | Phosphatidylethanolamine | 64 |
| DB03317 | HEC | Ferroheme C | 43 |
| DB02133 | CLA | Chlorophyll A | 25 |
| DB06755 | BCR | Beta carotene | 21 |
| DB09270 | U10 | Ubidecarenone | 21 |
| DB02182 | HEB | Hybrid Between B and C Type Hemes (Protoporphyrin Ixcontaining Fe) | 20 |
| DB03152 | BGL | B-2-Octylglucoside | 16 |
| DB01728 | PEF | 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine | 14 |
| DB02686 | UMQ | Undecyl-Beta-D-Maltopyranoside | 14 |
| DB08690 | UQ2 | Ubiquinone Q2 | 11 |
| DB07778 | FMX | (S)-famoxadone | 8 |
| DB09114 | PCF | Colfosceril palmitate | 8 |
| DB01117 | AOQ | Atovaquone | 7 |
| DB07401 | AZO | Azoxystrobin | 7 |
| DB00126 | ASC | Ascorbic acid | 5 |
| DB02777 | PLC | Diundecyl Phosphatidyl Choline | 4 |
| DB08453 | QNO | 2-Nonyl-4-quinolinol 1-oxide | 4 |
| DB08689 | UQ1 | Ubiquinone Q1 | 4 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| HEM | PROTOPORPHYRIN IX CONTAINING FE | 479 |
| CDL | CARDIOLIPIN | 257 |
| PC1 | 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE | 93 |
| PEE | 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine | 87 |
| 3PE | 1,2-Distearoyl-sn-glycerophosphoethanolamine | 84 |
| SMA | STIGMATELLIN A | 61 |
| U10 | UBIQUINONE-10 | 60 |
| UQ6 | 5-(3,7,11,15,19,23-HEXAMETHYL-TETRACOSA-2,6,10,14,18,22-HEXAENYL)-2,3-DIMETHOXY-6-METHYL-BENZENE-1,4-DIOL | 51 |
| MQ9 | MENAQUINONE-9 | 43 |
| PTY | PHOSPHATIDYLETHANOLAMINE | 39 |
| HEC | HEME C | 38 |
| 9YF | (2R)-2-(hexadecanoyloxy)-3-{[(S)-hydroxy{[(1R,2R,3R,4R,5R,6S)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}phosphoryl]oxy}propyl (9S)-9-methyloctadecanoate | 34 |
| LOP | (1R)-2-{[(R)-(2-AMINOETHOXY)(HYDROXY)PHOSPHORYL]OXY}-1-[(DODECANOYLOXY)METHYL]ETHYL (9Z)-OCTADEC-9-ENOATE | 33 |
| CLA | CHLOROPHYLL A | 32 |
| HDD | CIS-HEME D HYDROXYCHLORIN GAMMA-SPIROLACTONE | 31 |
| BCR | BETA-CAROTENE | 27 |
| UQ | Coenzyme Q10, (2Z,6E,10Z,14E,18E,22E,26Z)-isomer | 26 |
| 8PE | (2R)-3-{[(S)-(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-2-(tetradecanoyloxy)propyl octadecanoate | 25 |
| 7PH | (1R)-2-(dodecanoyloxy)-1-[(phosphonooxy)methyl]ethyl tetradecanoate | 24 |
| HEB | HEME B/C | 23 |